Moreadith Randall
SEC CIK 1301120 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SER | Serina Therapeutics, Inc. | CSO | 0 | — | $1.12M | 71 | 2025-06-30 | 2026-03-23 |
Most active insiders at SER, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Moreadith Randall | CSO | — | $501.5K |
| 2 | WILSON KAREN J | Dir | $54.7K | — |
| 3 | Marshall Richard Peter | Dir | $20.1K | — |
| 4 | Brannan Stephen K. | Dir | $2,030 | — |
| 5 | Venkatesan Jay | Dir | $1,048 | — |
| 6 | Bailey Gregory | Dir | — | — |
| 7 | LEDGER STEVEN A | CEO, Dir | — | — |
Transactions 71
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-24 | 2026-03-23 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $2.86 | -6,500 | 0 | -100% | -$18.6K |
| D | 2026-03-24 | 2026-03-23 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 6,500 | New | +$390 |
| D | 2026-03-20 | 2026-03-19 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +39.0K | 39.0K | New | +$2,340 |
| D | 2026-03-20 | 2026-03-19 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $2.50 | -39.0K | 0 | -100% | -$97.5K |
| D | 2026-02-03 | 2026-02-02 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 6,500 | New | +$390 |
| D | 2026-02-03 | 2026-02-02 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $3.03 | -6,500 | 0 | -100% | -$19.7K |
| D | 2026-01-29 | 2026-01-28 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 6,500 | New | +$390 |
| D | 2026-01-29 | 2026-01-28 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $3.57 | -6,500 | 0 | -100% | -$23.2K |
| D | 2026-01-23 | 2026-01-22 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +2,500 | 2,500 | New | +$150 |
| D | 2026-01-23 | 2026-01-22 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $2.95 | -2,500 | 0 | -100% | -$7,375 |
| DM | 2026-01-21 | 2026-01-20+ | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +4,000 | 2,000 | New | +$240 |
| DM | 2026-01-21 | 2026-01-20+ | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $3.04 | -4,000 | 0 | -100% | -$12.1K |
| DM | 2026-01-14 | 2026-01-13+ | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 5,416 | New | +$390 |
| DM | 2026-01-14 | 2026-01-13+ | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $2.50 | -6,500 | 0 | -100% | -$16.2K |
| D | 2026-01-09 | 2026-01-08 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $2.69 | -13.0K | 0 | -100% | -$35.0K |
| D | 2026-01-09 | 2026-01-08 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +13.0K | 13.0K | New | +$780 |
| D | 2025-12-29 | 2025-12-23 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $2.60 | -4,100 | 0 | -100% | -$10.7K |
| D | 2025-12-29 | 2025-12-23 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +4,100 | 4,100 | New | +$246 |
| D | 2025-12-23 | 2025-12-22 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $2.67 | -5,673 | 0 | -100% | -$15.1K |
| D | 2025-12-23 | 2025-12-22 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +5,673 | 5,673 | New | +$340.38 |
| D | 2025-12-17 | 2025-12-16 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $2.96 | -3,227 | 0 | -100% | -$9,552 |
| D | 2025-12-17 | 2025-12-16 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +3,227 | 3,227 | New | +$193.62 |
| D | 2025-12-16 | 2025-12-12 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $3.26 | -1,700 | 0 | -100% | -$5,542 |
| D | 2025-12-16 | 2025-12-12 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +1,700 | 1,700 | New | +$102 |
| D | 2025-12-12 | 2025-12-11 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $3.24 | -3,555 | 0 | -100% | -$11.5K |
| D | 2025-12-12 | 2025-12-11 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +3,555 | 3,555 | New | +$213.30 |
| D | 2025-12-11 | 2025-12-09 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +600 | 600 | New | +$36 |
| DM | 2025-12-11 | 2025-12-09+ | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $3.33 | -1,245 | 0 | -100% | -$4,147 |
| D | 2025-12-11 | 2025-12-10 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | A - Grant | $0.06 | +645 | 645 | New | +$38.70 |
| DM | 2025-12-04 | 2025-12-02+ | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $3.61 | -6,500 | 0 | -100% | -$23.5K |
| DM | 2025-12-04 | 2025-12-02+ | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 1,500 | New | +$390 |
| D | 2025-11-26 | 2025-11-25 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +5,965 | 11.9K | +100% | +$357.90 |
| D | 2025-11-26 | 2025-11-25 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $3.90 | -5,965 | 5,965 | -50% | -$23.3K |
| D | 2025-11-25 | 2025-11-24 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $3.94 | -535 | 0 | -100% | -$2,108 |
| D | 2025-11-25 | 2025-11-24 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +535 | 535 | New | +$32.10 |
| D | 2025-11-19 | 2025-11-18 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $3.75 | -6,500 | 0 | -100% | -$24.4K |
| D | 2025-11-19 | 2025-11-18 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 6,500 | New | +$390 |
| D | 2025-11-12 | 2025-11-10 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 6,500 | New | +$390 |
| D | 2025-11-12 | 2025-11-10 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $4.10 | -6,500 | 0 | -100% | -$26.6K |
| D | 2025-11-06 | 2025-11-05 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $4.24 | -3,398 | 0 | -100% | -$14.4K |
| D | 2025-11-06 | 2025-11-05 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +3,398 | 3,398 | New | +$203.88 |
| D | 2025-11-05 | 2025-11-04 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +3,102 | 3,102 | New | +$186.12 |
| D | 2025-11-05 | 2025-11-04 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $4.40 | -3,102 | 0 | -100% | -$13.6K |
| D | 2025-10-29 | 2025-10-28 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +5,551 | 5,551 | New | +$333.06 |
| D | 2025-10-29 | 2025-10-28 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $4.96 | -5,551 | 0 | -100% | -$27.5K |
| D | 2025-10-28 | 2025-10-27 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +949 | 949 | New | +$56.94 |
| D | 2025-10-28 | 2025-10-27 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $5.19 | -949 | 0 | -100% | -$4,925 |
| D | 2025-10-21 | 2025-10-20 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $4.97 | -6,500 | 0 | -100% | -$32.3K |
| D | 2025-10-21 | 2025-10-20 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 6,500 | New | +$390 |
| D | 2025-10-14 | 2025-10-13 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +4,326 | 4,326 | New | +$259.56 |
| D | 2025-10-14 | 2025-10-13 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $5.20 | -4,326 | 0 | -100% | -$22.5K |
| DM | 2025-08-27 | 2025-08-25+ | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +47.7K | 45.6K | New | +$2,860 |
| DM | 2025-08-27 | 2025-08-25+ | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $6.95 | -47.7K | 0 | -100% | -$331.4K |
| DM | 2025-08-20 | 2025-08-18+ | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +4,304 | 2,077 | New | +$258.24 |
| DM | 2025-08-20 | 2025-08-18+ | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $5.18 | -4,304 | 0 | -100% | -$22.3K |
| D | 2025-08-14 | 2025-08-12 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $5.25 | -5,500 | 0 | -100% | -$28.9K |
| D | 2025-08-14 | 2025-08-12 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +5,500 | 5,500 | New | +$330 |
| D | 2025-08-06 | 2025-08-04 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +5,500 | 5,500 | New | +$330 |
| D | 2025-08-06 | 2025-08-04 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $5.17 | -5,500 | 0 | -100% | -$28.4K |
| D | 2025-07-30 | 2025-07-29 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $6.50 | -4,196 | 0 | -100% | -$27.3K |
| D | 2025-07-30 | 2025-07-29 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +4,196 | 4,196 | New | +$251.76 |
| D | 2025-07-29 | 2025-07-28 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $5.89 | -6,500 | 0 | -100% | -$38.3K |
| D | 2025-07-29 | 2025-07-28 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 6,500 | New | +$390 |
| D | 2025-07-22 | 2025-07-21 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 6,500 | New | +$390 |
| D | 2025-07-22 | 2025-07-21 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $5.34 | -6,500 | 0 | -100% | -$34.7K |
| D | 2025-07-17 | 2025-07-14 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $5.01 | -6,500 | 0 | -100% | -$32.6K |
| D | 2025-07-17 | 2025-07-14 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 6,500 | New | +$390 |
| D | 2025-07-09 | 2025-07-07 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $5.67 | -6,500 | 0 | -100% | -$36.9K |
| D | 2025-07-09 | 2025-07-07 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 6,500 | New | +$390 |
| D | 2025-07-02 | 2025-06-30 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | M - OptEx | $0.06 | +6,500 | 6,500 | New | +$390 |
| D | 2025-07-02 | 2025-06-30 | SER | Serina Therapeutics, Inc. | Moreadith Randall | CSO | S - Sale+OE | $5.78 | -6,500 | 0 | -100% | -$37.6K |
Purchase Sale Sale after option exercise All abbreviations